Iambic Therapeutics
The Research Scientist I/II at Iambic Therapeutics will design and execute in vitro and ex vivo immunology assays to generate high-quality data for small‑molecule drug discovery programs. The role involves close collaboration with cross‑functional teams including medicinal chemistry, DMPK, in vivo pharmacology, computational biology, and CRO partners to support target validation, hit‑to‑lead, and lead optimization efforts.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2020
Iambic Therapeutics is a biotech company applying an AI-driven platform — including its Enchant and NeuralPLexer technologies — to tackle the most challenging design problems in drug discovery and address unmet patient needs. Its high-throughput experimental platform converts novel molecular designs into biological insights, enabling faster development of potential best-in-class and first-in-class medicines. Iambic maintains a proprietary clinical pipeline targeting cancers such as HER2-driven tumors and breast cancer, and pursues collaborations with pharmaceutical partners, including Bayer, to advance AI-driven drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iambic Therapeutics.
90% above the average for this role
Principal Associate Scientist
Xaira Therapeutics
Associate Scientist / Scientist, Immunology & Pharmacology
PharmaEssentia
Scientist, Immunology & Pharmacology (Hematologic Malignancies)
PharmaEssentia
Scientist I/II
Monte Rosa Therapeutics, Inc
Scientist/Senior Scientist
Flagship Pioneering, Inc.
Scientist, Bioscience Immunology
AstraZeneca